Date: June 12, 2025
Time: 11-12pm EDT / 5-6pm CEST
Title: Perspectives on Oligonucleotide Therapeutics: A discussion with Rebecca Miles, incoming president of OTS
Presentation Description:
In this interview, Dr. Rebecca Miles, the president-elect of the Oligonucleotide Therapeutics Society, will discuss the evolving landscape of oligonucleotide therapeutics. The discussion will highlight the industry’s advancements for targeted and individualized therapies as well as the society’s commitment to driving innovation and translating research into transformative treatments for patients worldwide.
